189 related articles for article (PubMed ID: 21604240)
1. Absolute/relative bioavailability and metabolism of dodeca-2E,4E,8Z,10E/Z-tetraenoic acid isobutylamides (tetraenes) after intravenous and oral single doses to rats.
Ardjomand-Woelkart K; Kollroser M; Magnes C; Sinner F; Frye RF; Derendorf H; Bauer R; Butterweck V
Planta Med; 2011 Nov; 77(16):1794-9. PubMed ID: 21604240
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and tissue distribution of dodeca-2E,4E,8E,10E/Z-tetraenoic acid isobutylamides after oral administration in rats.
Woelkart K; Frye RF; Derendorf H; Bauer R; Butterweck V
Planta Med; 2009 Oct; 75(12):1306-13. PubMed ID: 19399718
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and immunomodulatory effects of phytotherapeutic lozenges (bonbons) with Echinacea purpurea extract.
Guiotto P; Woelkart K; Grabnar I; Voinovich D; Perissutti B; Invernizzi S; Granzotto M; Bauer R
Phytomedicine; 2008 Aug; 15(8):547-54. PubMed ID: 18583121
[TBL] [Abstract][Full Text] [Related]
4. Absorption of dodeca-2E,4E,8Z,10E/Z-tetraenoic acid isobutylamides after oral application of Echinacea purpurea tincture.
Dietz B; Heilmann J; Bauer R
Planta Med; 2001 Dec; 67(9):863-4. PubMed ID: 11745026
[TBL] [Abstract][Full Text] [Related]
5. The bioanalysis of the major Echinacea purpurea constituents dodeca-2E,4E,8Z,10E/Z-tetraenoic acid isobutylamides in human plasma using LC-MS/MS.
Goey AK; Rosing H; Meijerman I; Sparidans RW; Schellens JH; Beijnen JH
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Aug; 902():151-6. PubMed ID: 22770780
[TBL] [Abstract][Full Text] [Related]
6. Possible role of fat tissue in the pharmacokinetics of Dodeca-2E,4E,8Z,10E/Z-tetraenoic acid isobutylamides after oral administration of Echinacea angustifolia extract in rats.
Jedlinszki N; Rédei D; Haller J; Freund TF; Hohmann J; Zupkó I
Nat Prod Commun; 2014 Jun; 9(6):843-5. PubMed ID: 25115096
[TBL] [Abstract][Full Text] [Related]
7. Bioavailability and pharmacokinetics of alkamides from the roots of Echinacea angustifolia in humans.
Woelkart K; Koidl C; Grisold A; Gangemi JD; Turner RB; Marth E; Bauer R
J Clin Pharmacol; 2005 Jun; 45(6):683-9. PubMed ID: 15901750
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of the main alkamides after administration of three different Echinacea purpurea preparations in humans.
Woelkart K; Dittrich P; Beubler E; Pinl F; Schoop R; Suter A; Bauer R
Planta Med; 2008 May; 74(6):651-6. PubMed ID: 18240099
[TBL] [Abstract][Full Text] [Related]
9. Bioavailability and pharmacokinetics of Echinacea purpurea preparations and their interaction with the immune system.
Woelkart K; Marth E; Suter A; Schoop R; Raggam RB; Koidl C; Kleinhappl B; Bauer R
Int J Clin Pharmacol Ther; 2006 Sep; 44(9):401-8. PubMed ID: 16995328
[TBL] [Abstract][Full Text] [Related]
10. Purification of alkylamides from Echinacea angustifolia (DC.) Hell. Roots by high-speed countercurrent chromatography.
Lopes-Lutz D; Mudge E; Ippolito R; Brown P; Schieber A
J Agric Food Chem; 2011 Jan; 59(2):491-4. PubMed ID: 21190380
[TBL] [Abstract][Full Text] [Related]
11. Effect of temperature on stability of marker constituents in Echinacea purpurea root formulations.
Livesey J; Awang DV; Arnason JT; Letchamo W; Barrett M; Pennyroyal G
Phytomedicine; 1999 Nov; 6(5):347-9. PubMed ID: 11962542
[TBL] [Abstract][Full Text] [Related]
12. Comparative metabolomics approach coupled with cell- and gene-based assays for species classification and anti-inflammatory bioactivity validation of Echinacea plants.
Hou CC; Chen CH; Yang NS; Chen YP; Lo CP; Wang SY; Tien YJ; Tsai PW; Shyur LF
J Nutr Biochem; 2010 Nov; 21(11):1045-59. PubMed ID: 20005088
[TBL] [Abstract][Full Text] [Related]
13. Transport of alkamides from Echinacea species through Caco-2 monolayers.
Jager H; Meinel L; Dietz B; Lapke C; Bauer R; Merkle HP; Heilmann J
Planta Med; 2002 May; 68(5):469-71. PubMed ID: 12058332
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and immunomodulatory effect of lipophilic Echinacea extract formulated in softgel capsules.
Dall'Acqua S; Perissutti B; Grabnar I; Farra R; Comar M; Agostinis C; Caristi G; Golob S; Voinovich D
Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):8-14. PubMed ID: 26455420
[TBL] [Abstract][Full Text] [Related]
15. Isomeric C12-alkamides from the roots of Echinacea purpurea improve basal and insulin-dependent glucose uptake in 3T3-L1 adipocytes.
Kotowska D; El-Houri RB; Borkowski K; Petersen RK; Fretté XC; Wolber G; Grevsen K; Christensen KB; Christensen LP; Kristiansen K
Planta Med; 2014 Dec; 80(18):1712-20. PubMed ID: 25371981
[TBL] [Abstract][Full Text] [Related]
16. Light-mediated antifungal activity of Echinacea extracts.
Binns SE; Purgina B; Bergeron C; Smith ML; Ball L; Baum BR; Arnason JT
Planta Med; 2000 Apr; 66(3):241-4. PubMed ID: 10821050
[TBL] [Abstract][Full Text] [Related]
17. LC-MS N-alkylamide profiling of an ethanolic Anacyclus pyrethrum root extract.
Boonen J; Sharma V; Dixit VK; Burvenich C; De Spiegeleer B
Planta Med; 2012 Nov; 78(16):1787-95. PubMed ID: 23047251
[TBL] [Abstract][Full Text] [Related]
18. Chromatographic methods for metabolite profiling of virus- and phytoplasma-infected plants of Echinacea purpurea.
Pellati F; Epifano F; Contaldo N; Orlandini G; Cavicchi L; Genovese S; Bertelli D; Benvenuti S; Curini M; Bertaccini A; Bellardi MG
J Agric Food Chem; 2011 Oct; 59(19):10425-34. PubMed ID: 21830789
[TBL] [Abstract][Full Text] [Related]
19. Echinacea and its alkylamides: effects on the influenza A-induced secretion of cytokines, chemokines, and PGE₂ from RAW 264.7 macrophage-like cells.
Cech NB; Kandhi V; Davis JM; Hamilton A; Eads D; Laster SM
Int Immunopharmacol; 2010 Oct; 10(10):1268-78. PubMed ID: 20674883
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous analysis of caffeic acid derivatives and alkamides in roots and extracts of Echinacea purpurea by high-performance liquid chromatography-photodiode array detection-electrospray mass spectrometry.
Luo XB; Chen B; Yao SZ; Zeng JG
J Chromatogr A; 2003 Jan; 986(1):73-81. PubMed ID: 12585324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
